On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
TuesdayJul 16, 2024 3:15 pm

QualityStocksNewsBreaks – U.S. Government and Social Media Giants Tackle Synthetic Drug Distribution

The United States government’s recent memorandum with major social media companies, including Meta Platforms (NASDAQ: META), X and Snap (NYSE: SNAP), marks a significant step in the fight against the distribution of synthetic drugs online. Snap, known for its Snapchat application, is at the forefront of this initiative, showcasing its commitment to corporate responsibility. This collaboration aims to leverage the extensive reach and influence of these platforms to address a critical public health concern. Snap, alongside its peers Meta and X, plays a pivotal role in the digital ecosystem, with millions of users engaging on their platforms daily. The agreement to curb…

Continue Reading

TuesdayJul 16, 2024 1:27 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Makes Management Announcement, Plans for Strategic Growth

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is preparing for growth by executing a strategic growth plan. A key element of the plan includes expanding the company’s management team to enable efficient handling of a greater workload of projects and initiatives. With that in mind, the company has named Nelson Cabatuan as consulting chief strategic financial advisor; Cabatuan is currently serving as Lexaria CFO. In his new role, Cabatuan will leverage his skills in corporate finance and strategic industry relationships to focus on strategic opportunities. In addition, Lexaria is working on other research and development projects…

Continue Reading

TuesdayJul 16, 2024 1:05 pm

QualityStocksNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Secures FDA Approval for New Form of Buntanetap

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), today announced receipt of approval from the U.S. Food and Drug Administration (“FDA”) to transition to a new solid form of buntanetap in future clinical trials. “In June 2024, Annovis announced the filing of a composition of matter patent for the new crystal form of buntanetap and a provisional patent for the manufacturing process of this new form,” the announcement reads. “The company conducted comprehensive bridge studies in various solvents and in animals, comparing the old…

Continue Reading

MondayJul 15, 2024 1:27 pm

QualityStocksNewsBreaks – Volcon Inc. (NASDAQ: VLCN) Closes $12M Registered Direct

Volcon (NASDAQ: VLCN), an all-electric power sports company producing high-quality and sustainable electric vehicles for the outdoor community, recently closed a registered direct offering. The company secured aggregate gross proceeds of approximately $12 million in the transaction that closed on July 12, 2024. Aegis Capital Corp. acted as the exclusive placement agent for the offering. To view the full press release, visit https://ibn.fm/xoB2G About Volcon Inc. Based in the Austin, Texas area, Volcon was founded as the first all-electric power sports company producing high-quality and sustainable electric vehicles for the outdoor community. Volcon electric vehicles are the future of off-roading,…

Continue Reading

MondayJul 15, 2024 12:15 pm

QualityStocksNewsBreaks – Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF) Announces Completion of Business Combination with G Mining Ventures

Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF), a leading gold explorer in the Guiana Shield, has completed its business combination with G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF). The business combination was completed through a court-approved plan of arrangement under the Canada Business Corporations Act after GMIN shareholders and Reunion Gold securityholders approved the plan; the Ontario Superior Court of Justice also approved the transaction. According to the announcement, a newly incorporated successor issuer will hold and manage the combined business of GMIN and Reunion Gold and has acquired all of the issued and outstanding common shares in the capital of…

Continue Reading

MondayJul 15, 2024 11:15 am

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Obtains Notice of Allowance for Key Trademark Identified as ‘Integral’ to Platform Technology

Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceutical products, has received a Notice of Allowance from the United States Patent and Trademark Office (“USPTO”). According to the announcement, the notice means that the USPTO anticipates granting the trademark registration covering the mark “AVERSA” after completing administrative processes. Nutriband's proprietary AVERSA(TM) abuse deterrent transdermal technology works to incorporate aversive agents into transdermal patches that make an experience unpleasant, thereby discouraging abuse of substances. This technology is especially significant for drugs such as fentanyl, which have a high potential for abuse. The company’s lead product under development is AVERSA Fentanyl. Nutriband is…

Continue Reading

MondayJul 15, 2024 10:40 am

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Successful Preclinical Results In-Vivo Proof-of-Concept Psoriatic Human Skin Model Study

Scinai Immunotherapeutics (NASDAQ: SCNI), a biotechnology company focused on developing inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservices business unit, is reporting recent study results. According to the announcement, the successful in-vivo preclinical results are from SCNI’s innovative anti IL-17A/F VHH antibody fragment (“NanoAb”), which is being studied as a local, first-of-its-kind, intralesional biological treatment for from mild to moderate plaque psoriasis. An estimated million patients are diagnosed with plaque psoriasis in the United States, Japan and Europe. Scinai's product candidate is designed to address the major shortcomings of…

Continue Reading

FridayJul 12, 2024 3:31 pm

QualityStocksNewsBreaks – Software Effective Solutions Corp. (SFWJ) Ideally Positioned as DEA’s Move to Reclassify Cannabis Signals New Era

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana) noted a historic milestone as the U.S. Drug Enforcement Administration (“DEA”) moves to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act. “The company released an announcement from CEO Jose Gabriel Diaz and observed that the ‘monumental decision,’ based on recommendations from the U.S. Department of Health and Human Services, signifies a significant shift in U.S. drug policy… While there may be work left to do, the initial rescheduling is certainly noteworthy. The announcement from MedCana noted that cannabis has been unjustly categorized as a Schedule I substance alongside…

Continue Reading

FridayJul 12, 2024 3:03 pm

QualityStocksNewsBreaks – Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) Enhancing Asset Portfolio with Fully Funded Phase II Drilling Program

Emperor Metals (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) is an advanced-stage gold exploration company focused on proving and developing the substantial resource potential of its flagship Duquesne West Gold Project located in the Tier 1 district of the Southern Abitibi Greenstone belt of Rouyn-Noranda, Quebec. “The company announced an ambitious 8,000-meter drill program and 8,000-meter of historical core assaying at its Duquesne West Gold Project. This extensive drilling program is designed to expand the current resource base and explore new zones of mineralization within the project area. This strategic move not only aims to enhance Emperor’s asset portfolio but also…

Continue Reading

FridayJul 12, 2024 2:31 pm

QualityStocksNewsBreaks – Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) Poised as 2024 Promises to Be ‘Milestone Year’

Tartisan Nickel (CSE: TN) (OTCQB: TTSRF), a Canadian mineral and battery material exploration and mining development company, recently announced an ambitious plan to complete an all-season access road at its flagship Kenbridge Nickel Project in Ontario. “As a critical initiative for the 2024 calendar year, its management noted its integral role in improving the property’s value, aligning with Indigenous communities… To live up to its promise, Tartisan appointed Gregory (Greg) Edwards, B.Sc., Geo Eng., to serve as Project Manager for the Kenbridge Nickel Project and the company’s First Nations Liaison. His appointment was informed by his consistent desire to work…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered